Indoco Remedies shares slide after USFDA issues seven Goa plant observations
Indoco Remedies’ shares fell as much as 5.5% on Sept. 7 after the US Food and Drug Administration issued seven observations following an inspection of its Plant II (Sterile) facility in Goa.
Shares of Indoco Remedies Ltd. fell as much as 5.5% on Monday, September 7, after the US Food and Drug Administration (USFDA) issued 7 observations to the company following an inspection of its manufacturing facility in Goa. The USFDA inspected the company’s Plant II (Sterile) facility in Goa.